ELMMB logo
Facebook logo Twitter logo
Menu
Drug Alerts and Withdrawals

Drug Alerts and Withdrawals

Drug Alerts and Withdrawals
 For more information about the MHRA click here 
 For MHRA Drug Safety Updates click here

When the MHRA, or occasionally another regulatory body in another country, such as the FDA, release advice, it is sometime necessary to produce additional local guidance.  This aims to be both clear and concise advice to healthcare professionals on the local action required to implement or respond to alerts issued by the MHRA or other bodies.  These memorandums are available below for reference, once they have been circulated to the relevant professionals in primary and secondary care:

MHRA News Stories.

 
15th Sept 2021          MHRA Press Release The MHRA is advising anyone experiencing skin redness or burning sensations after
                                     they have stopped using these creams or ointments to seek advice from their health professional before
                                     using these products again.
 9th August 2021       MHRA Press Release MHRA recalls contaminated Irbesartan-batches as a precautionary measure. 
                                                                        Patients should not stop any treatments without consulting their doctor or pharmacist.
 8th July 2021             MHRA Press Release First progesterone-only contraceptive pills to be available to purchase from pharmacies      
 1st July 2021             Company led medicines recall: Morphine Syringe 50mg/50ml [unlicensed medicine] and Magnesium Sulphate
                                                                                         8mmol/20ml infusion [unlicensed medicine]
 17th June 2021         MHRA Press Release  MHRA recalls contaminated Irbesartan and Losartan batches as precautionary measure
 8th June 2021           MHRA Press Release  Over 3 million medicines and devices seized in UK as part of global crackdown
 28th May 2021         MHRA Press Release A personal trainer sentenced to 31 months in jail for selling and supplying unlicensed and                                                                                prescription medicines, together with Anabolic steroids, to the public.        
 4th May 2021           MHRA Press Release  MHRA announces appointment of Chief Safety Officer
 

MHRA Company-led Drug alerts

click here to access the most recent alerts

Items In This Category

 TitleCreatedDownload
application/pdfIkervis eye drops 1mg _1mL_Class_2_Medicines_Recall_Santen_UK_Limited.pdf (92KB)16/09/2021Download
 Brief description of the problem SANTEN Oy (trading as Santen UK Limited) are recalling the above batches of products as a precautionary measure due to detection of particles/crystals of the active... 
application/pdfRosuvastatin Class 4 medicines recall EL__21_A_21_sept.pdf (186KB)14/09/2021Download
 Accord Healthcare have informed us of an error with the patient information leaflets (PILs) that have been packaged in the above batches of products. These were an older version of the PIL which did... 
application/pdfMetformin hcl oral sol 500mg per 5ml Class 2 meds recall MHRA 250821.pdf (100KB)31/08/2021Download
 Rosemont Pharmaceuticals Limited is recalling all unexpired stock of the above product from pharmacies and wholesalers as a precautionary measure due to the identification level of an impurity above... 
application/pdfIrbesartan Class 2 meds recall MHRAEL__21_A_19_FINAL_09-08-21.pdf (182KB)09/08/2021Download
 Specific batches of the above products are recalled by the Marketing Authorisation Holders and parallel distributor companies as a precautionary measure due to contamination with an impurity called... 
application/pdfAmoxicillin 500mg 5ml powder for susp Cl 4 med defect EL__21_A_18.pdf (131KB)19/07/2021Download
 Brown & Burk UK Limited would like to notify you of an error regarding specific batches of Amoxicillin 500 mg/ 5 ml Powder for oral suspension, sold and distributed in the UK. The product... 
application/pdfSevredol 10mg tabs Class 4 meds defect July 21 EL__21_A_17.pdf (144KB)14/07/2021Download
 Napp Pharmaceuticals Limited would like to notify you of an error regarding specific batches of Sevredol 10 mg Tablets and Sevredol 20 mg Tablets, sold and distributed in the UK. The error... 
application/pdfTetralysal 300mg class 4 meds defect info EL__21_A_16_Final 0721.pdf (76KB)07/07/2021Download
 Galderma UK would like to notify you of an error identified by Galderma regarding specific batches of Tetralysal 300mg Hard Capsules, sold and distributed in the UK. The error identified relates to... 
application/pdfXomolix 2.5mg per ml soln for injection_ class 2 medicines recall_EL__21_A_15_Final__2 0721_.pdf (162KB)01/07/2021Download
 Kyowa Kirin Limited is recalling the above batches as a precautionary measure, due to the reports of glass and cellulose fibre contamination, which was identified during stability and reference... 
application/pdfIrbesartan Class 2 medicines recall June 21 EL__21_A_14_FINAL.pdf (128KB)18/06/2021Download
  
application/pdfCo-codamol 30_500mg eff NatPSA-2021-004-MHRA-PL_June 21.pdf (124KB)16/06/2021Download
 Zentiva Pharma UK Limited have notified the MHRA of an issue related to the homogeneity of a batch of Co-codamol 30/500 Effervescent Tablets that could result in a potential underdose and lack of... 
application/pdfSyonell 250_500mg tablets Class 4 meds recall EL__21_A_11 040521.pdf (78KB)04/05/2021Download
 Lupin Healthcare (UK) Limited has informed us of a discrepancy with the product packaging for several batches of Syonell 250mg Gastro-Resistant Tablets and Syonell 500mg Gastro-Resistant Tablets.... 
application/pdfTrimethorpim 200mg tab Class 2 meds recall EL__21_A_10_FINAL 220421.pdf (121KB)22/04/2021Download
 Ennogen Pharma Limited are recalling the above batch as a precautionary measure due to the investigation of market complaints. The Marketing Authorisation Holder has received two complaints related... 
Page: [1] [2] [3] [4] [5] [6] [7] [8] [9]
[ Next » ]